Asherman’s Syndrome


Asherman’s syndrome is a rare, acquired, gynecological disorder of the uterus. It is characterized by the bonding of scar tissue that lines the walls of the uterus, which decreases the volume of the uterine cavity.

Cell therapy has been proposed as an ideal alternative for Asherman’s syndrome, including the employment of cells, platelet-rich plasma, and growth factors as therapeutic agents. The mechanisms of action of cell therapy include cytokine induction, growth factor production, and natural killer cell activity reduction.